Open study of the efficacy and mechanism of action of topical imiquimod in basal cell carcinoma.

@article{Vidal2004OpenSO,
  title={Open study of the efficacy and mechanism of action of topical imiquimod in basal cell carcinoma.},
  author={David Vidal and Xavier Mat{\'i}as-Guiu and Agust{\'i}n Alomar},
  journal={Clinical and experimental dermatology},
  year={2004},
  volume={29 5},
  pages={518-25}
}
Imiquimod is an immune-response modifier that has been shown to be effective in the treatment of superficial and nodular basal cell carcinoma (BCC). The objective of this open-label study was to investigate the effectiveness of imiquimod 5% cream in superficial, nodular, and infiltrative BCC. Fifty-five Caucasian patients with primary BCC measuring 8 mm or more in diameter with a superficial, nodular, or infiltrative histological pattern were included in the study. Four groups of BCC (A, B, C… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 13 extracted citations

Radiation dermatitis: clinical presentation, pathophysiology, and treatment 2006.

Journal of the American Academy of Dermatology • 2006
View 2 Excerpts
Highly Influenced

Blessing or curse? Proteomics in granzyme research.

Proteomics. Clinical applications • 2014
View 2 Excerpts

Trial watch

Oncoimmunology • 2012

Similar Papers

Loading similar papers…